MedTrace Logo

Cancer Patients Decision Making and Family Communication About Secondary Findings From Tumor Genomic Profiling

NCT02713334 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 495

Last updated 2025-07-11

No results posted yet for this study

Summary

The objective of this protocol is to characterize cancer patients' responses to learning their secondary findings arising from tumor genomic profiling, and the process and outcomes of their decisions to communicate these results to their families.

Conditions

  • Tumor Genomic Profiling

Interventions

BEHAVIORAL

survey

BEHAVIORAL

semi-structured interview

Sponsors & Collaborators

Principal Investigators

  • Jada Hamiliton, PhD, MPH · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-25
Primary Completion
2026-02-25
Completion
2026-02-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02713334 on ClinicalTrials.gov